Hyeong Kim - Aprogen Healthcare Internal Auditor
| 109960 Stock | KRW 636.00 3.00 0.47% |
Executive
Hyeong Kim is Internal Auditor of Aprogen Healthcare Games since 2017.
| Age | 59 |
| Tenure | 7 years |
| Phone | 82 3 1782 3438 |
| Web | https://www.aprogen-hng.com |
Aprogen Healthcare Management Efficiency
Aprogen Healthcare's management efficiency ratios could be used to measure how well Aprogen Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sang Lee | SK Holdings Co | 59 | |
| Thomas Schemera | Hyundai Motor Co | 59 | |
| In Kim | Samsung Life | N/A | |
| JongIn Lee | Woori Financial Group | 64 | |
| Peter Schreier | Hyundai Motor Co | 70 | |
| Thomas Schemera | Hyundai Motor Co | 59 | |
| Jae Chey | SK Holdings Co | 60 | |
| Hwa Park | Woori Financial Group | 62 | |
| ByungDoo Kim | SK Holdings Co | 56 | |
| Sudong Yeo | Hyundai Motor Co | 64 | |
| Su Cho | Woori Financial Group | N/A | |
| Peter Schreier | Hyundai Motor Co | 70 | |
| Hong Choi | Woori Financial Group | N/A | |
| Sudong Yeo | Hyundai Motor Co | 64 | |
| Joe Ahn | SK Holdings Co | N/A | |
| TaeJin Park | SK Holdings Co | 62 | |
| ByoungKwon Woo | Woori Financial Group | 59 | |
| DongYeun Lee | Woori Financial Group | 63 | |
| SungWook Lee | Woori Financial Group | 58 | |
| EuiDong Jang | SK Holdings Co | 60 | |
| JunKun Lee | Samsung Life | N/A | |
Management Performance
| Return On Equity | 3.02 | |||
| Return On Asset | -0.0075 |
Aprogen Healthcare Games Leadership Team
Elected by the shareholders, the Aprogen Healthcare's board of directors comprises two types of representatives: Aprogen Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aprogen. The board's role is to monitor Aprogen Healthcare's management team and ensure that shareholders' interests are well served. Aprogen Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aprogen Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Je Park, Internal Auditor | ||
| Chang Jung, Managing Director | ||
| Hui Chang, Chief Officer | ||
| Xiao Li, Non-Executive Independent Director | ||
| Sun Park, Director | ||
| JungGwon Lee, Sr Division | ||
| Jang Park, Assistant Managing Director | ||
| ChangYong Jung, Managing Division | ||
| Wei Zhou, Director | ||
| Jae Kim, Chief Executive Officer, Director | ||
| Seong Kang, Non-Executive Independent Director | ||
| Yu Kim, Assistant Managing Director | ||
| Wei Zhao, Director | ||
| YuChan Kim, Managing Division | ||
| Jin Jung, Director | ||
| JangWoon Park, Chief Director | ||
| Xinhui Wu, Director | ||
| Fei Wang, Non-Executive Independent Director | ||
| Hyeong Kim, Internal Auditor | ||
| Jeong Lee, Managing Director | ||
| Shanhu Xing, CEO, Director | ||
| Su Yim, Non-Executive Independent Director |
Aprogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aprogen Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.02 | |||
| Return On Asset | -0.0075 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 126 B | |||
| Shares Outstanding | 178.7 M | |||
| Shares Owned By Insiders | 59.70 % | |||
| Shares Owned By Institutions | 0.39 % | |||
| Price To Sales | 7.70 X | |||
| Revenue | 8.42 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aprogen Healthcare Games. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Aprogen Healthcare Games information on this page should be used as a complementary analysis to other Aprogen Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Aprogen Stock analysis
When running Aprogen Healthcare's price analysis, check to measure Aprogen Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aprogen Healthcare is operating at the current time. Most of Aprogen Healthcare's value examination focuses on studying past and present price action to predict the probability of Aprogen Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aprogen Healthcare's price. Additionally, you may evaluate how the addition of Aprogen Healthcare to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |